Skip to main content
Premium Trial:

Request an Annual Quote

Cave-Dwelling Beetles Had High Genetic Diversity Before Moving Underground

Cave beetles already had high levels of genetic diversity when they made the move to subterranean life, a new study has found. Researchers from the Institute of Evolutionary Biology at the Universitat Pompeu Fabra compared proteomic, transcriptomic, and genomic data from six beetle lineages that live both above- and underground: Myxophaga, Archostemata, Adephaga, and Polyphaga and the outgroups Neuroptera and Strepsiptera. Unexpectedly, the researchers did not find a high level of genetic differences between the surface- and cave-dwelling beetles. Instead, they report in Nature Communications that genomic exaptation may have enabled their underground life. "Genomic changes in the gene repertoire are observed before the colonization of the caves. In these ancestors there were more genetic changes than between the close species from the caves and their terrestrial sister species," senior author Rosa Fernández, principal investigator at IBE, says in a statement. She and her colleagues note that both parallel and convergent evolution also influenced the beetles' gene repertoires.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.